--Lexicon Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has approved INPEFA™, a once-daily oral tablet to reduce the risk of cardiovascular death, hospitalization ...
THE WOODLANDS, Texas, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (LXRX) (Nasdaq: LXRX) today announced that Express Scripts, the pharmacy benefits management (PBM) business of The ...
Express Scripts has determined that it will list INPEFA as a preferred product on Medicare national formularies on November 1, 2023 THE WOODLANDS, Texas, Oct. 09, 2023 (GLOBE NEWSWIRE) -- Lexicon ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback